Skip to main content

Table 2 Prevalence of atopy and atopic disease by tuberculosis status

From: Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru

 

No TB N = 161 n/N (%)

TB N = 177 n/N (%)

p-value*

Atopic disease

 Rhinitis symptoms

57/160 (35.6)

41/176 (23.3)

0.01

 Rhinitis diagnosis

18/160 (11.3)

21/176 (11.9)

0.85

 Previous wheeze

36/160 (22.5)

36/176 (20.5)

0.65

 Asthma diagnosis

12/160 (7.5)

10/176 (5.7)

0.50

 Positive bronchodilator response

5/139 (3.6)

7/159 (4.4)

0.72

 Family history rhinitis/eczema

17/141 (12.1)

35/152 (23.0)

0.01

Atopy (positive skin prick tests, SPT)

Positive SPT (any)

90/158 (57.0)

76 (42.9)

0.01

House dust mite

 Dermatophagoides farinae

43/157 (27.4)

47 (26.6)

0.86

 Dermatophagoides pteronyssinus

49/157 (31.2)

50 (28.3)

0.55

 Blomia tropicalis

36/156 (23.1)

39 (22.0)

0.82

Cockroach

 Blattella germanica

27/157 (17.2)

32 (18.1)

0.83

 Periplaneta americana

24/157 (15.3)

14 (7.9)

0.03

Pets

   

 Cat dander

9/157 (5.7)

10 (5.7)

0.97

 Dog dander

9/156 (5.8)

11 (6.2)

0.86

Grasses

   

 Ryegrass

4/158 (2.5)

3 (1.7)

0.59

 Grass mix

7/157 (4.5)

5 (2.8)

0.42

Mould

 Aspergillus fumigatus

8/158 (5.1)

7 (4.0)

0.62

 Alternaria alternata

10/156 (6.4)

6 (3.4)

0.20

Airway inflammation

FeNO (ppb)a

 Normal

122/158 (77.2)

134/176 (76.1)

0.23

 Intermediate

18/158 (11.4)

29/176 (16.5)

 

 High

18/158 (11.4)

13/176 (7.4)

 
  1. * Using the Chi2 test; aFraction of exhaled nitric oxide (ppb); normal (adults < 25; children < 20), intermediate (adults ≥25 and ≤ 50; children ≥20 and ≤ 35), high (adults > 50; children > 35)